Viewing Study NCT05681195


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2025-12-29 @ 4:06 PM
Study NCT ID: NCT05681195
Status: RECRUITING
Last Update Posted: 2025-05-20
First Post: 2022-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas
Sponsor: Baptist Health South Florida
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module